SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001628280-23-004707
Filing Date
2023-02-23
Accepted
2023-02-23 08:33:30
Documents
6
Effectiveness Date
2023-02-23

Document Format Files

Seq Description Document Type Size
1 POSASR c4t-posasr.htm POSASR 485088
2 EX-FILING FEES exhibit107asr.htm EX-FILING FEES 67160
3 EX-5.1 exhibit51.htm EX-5.1 14631
4 EX-23.1 exhibit231asr.htm EX-23.1 2344
5 image_3a.jpg GRAPHIC 269
6 image_5.jpg GRAPHIC 5553
  Complete submission text file 0001628280-23-004707.txt   578492
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-260972 | Film No.: 23656065
SIC: 2836 Biological Products, (No Diagnostic Substances)